Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,805.70
(
0.60%
)
News Focus
News Focus
Post# of 257660
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

oldberkeley

Send PM Follow Ignore
Followers 58
Posts 5142
Boards Moderated 0
Alias Born 07/23/2007

oldberkeley

Re: DewDiligence post# 126994

Wednesday, 09/21/2011 2:01:37 PM

Wednesday, September 21, 2011 2:01:37 PM

Post# of 257660

The same way MNTA sued Teva for patent infringement in Dec 2010.

I have to admit that I've always been a bit hazy about their reasoning.

Did they say about TEVA and will they say about Amphastar that it is impossible to manufacture a generic enoxaparin without using one of their patented manufacturing methods, therefor an infringement must have occurred?




Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today